A Scoring Tool to Predict Pulmonary Complications in Severe Leptospirosis with Kidney Failure
- PMID: 35051123
- PMCID: PMC8778471
- DOI: 10.3390/tropicalmed7010007
A Scoring Tool to Predict Pulmonary Complications in Severe Leptospirosis with Kidney Failure
Abstract
Rapid identification of patients likely to develop pulmonary complications in severe leptospirosis is crucial to prompt aggressive management and improve survival. The following article is a cohort study of leptospirosis patients admitted at the National Kidney and Transplant Institute (NKTI). Logistic regression was used to predict pulmonary complications and obtain a scoring tool. The Kaplan-Meir method was used to describe survival rates. Among 380 patients with severe leptospirosis and kidney failure, the overall mortality was 14%, with pulmonary hemorrhage as the most common cause. In total, there were 85 (22.4%) individuals who developed pulmonary complications, the majority (95.3%) were observed within three days of admission. Among the patients with pulmonary complications, 56.5% died. Patients placed on mechanical ventilation had an 82.1% mortality rate. Multivariate analyses showed that dyspnea (OR = 28.76, p < 0.0001), hemoptysis (OR = 20.73, p < 0.0001), diabetes (OR = 10.21, p < 0.0001), renal replacement therapy (RRT) requirement (OR = 6.25, p < 0.0001), thrombocytopenia (OR = 3.54, p < 0.0029), and oliguria/anuria (OR = 3.15, p < 0.0108) were significantly associated with pulmonary complications. A scoring index was developed termed THe-RADS score (Thrombocytopenia, Hemoptysis, RRT, Anuria, Diabetes, Shortness of breath). The odds of developing pulmonary complications were 13.90 times higher among patients with a score >2 (63% sensitivity, 88% specificity). Pulmonary complications in severe leptospirosis with kidney failure have high mortality and warrant timely and aggressive management.
Keywords: mortality; predictors; pulmonary complications; pulmonary hemorrhage; severe leptospirosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization . Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. World Health Organization; Geneva, Switzerland: 2003.
-
- Republic of the Philippines Department of Health. [(accessed on 18 September 2018)]; Available online: www.doh.gov.ph.
LinkOut - more resources
Full Text Sources